Five Prime Therapeutics Obtains $62,400,000 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3cee61ee-0ee1-4a9b-a02d-75ce4dbea1a4 - Date
9/18/2013 - Company Name
Five Prime Therapeutics - Mailing Address
Two Corporate Dr South San Francisco, CA 94080 - Company Description
FivePrime (NASDAQ: FPRX) is a drug discovery and development company primarily focused on therapeutic proteins. The Company is creating a new paradigm in drug discovery by leveraging the Pharmanome(TM) – the entire set of pharmaceutically relevant genes and proteins. - Website
http://www.fiveprime.com - Transaction Type
IPO - Transaction Amount
$62,400,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes are on file with company statements at the SEC. - M&A Terms
